[Emoxipine correction of lipid peroxidation disorders in patients with osteoarthrosis deformans].
In 54 patients with osteoarthrosis deformans traditional treatment was supplemented by an antioxidant agent emoxipin. The drug inhibited lipid peroxidation, activated the antioxidant defense system with simultaneous regression of clinical manifestations. Results of the investigation evidence the efficiency of emoxipin in osteoarthrosis deformans.
Shved
N I
NI
Belozetskaia-Smiian
S I
SI
D000975:Antioxidants / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D008875:Middle Aged; D010003:Osteoarthritis / Q000097:blood / Q000188:drug therapy*; D010847:Picolines / Q000627:therapeutic use*
D000975:Antioxidants; D010847:Picolines; C009820:6-methyl-2-ethyl-3-hydroxypyridine
Korrektsiia émoksipinom narusheniĭ perekisnogo okisleniia lipidov u bol'nykh deformiruiushchim osteoartrozom.